Patient group | Variable | Unit | Reference values (P5–P95) | P25 | P50 | P75 | |
Intracranial haemorrhage (n=11) | MBP | (μg/l) | 0.2–1.2 | 1.3 | 6.5 | 13.1 | |
CSF S-100 | (μg/l) | 0.7–2.0 | 1.4 | 7.5 | 22.90 | ||
Lactate | (μmmol/l) | 1380–1900 | 2250 | 2338 | 3000 | ||
Qalb | ×10−3 | 1.7–9.0 | 8.9 | 19.0 | 22.5 | ||
Serum S-100 | (μg/l) | 0–0.05 | 0.01 | 0.03** | 0.07 | ||
Benign mass lesion (n=52) | MBP | (μg/l) | 0.2–1.2 | 1.0 | 1.8 | 3.2 | |
CSF S-100 | (μg/l) | 0.7–2.0 | 2.5 | 10.5 | 30.5 | ||
Lactate | (μmmol/l) | 1380–1900 | 1941 | 2644 | 3070 | ||
Qalb | ×10−3 | 1.7–9.0 | 9.3 | 23.3 | 73.8 | ||
Serum S-100 | (μg/l) | 0–0.05 | 0.06 | 0.111-150 | 0.19 | ||
Malignant neoplastic disease (n=28) | MBP | (μg/l) | 0.2–1.2 | 1.2 | 2.9 | 5.8 | |
CSF S-100 | (μg/l) | 0.7–2.0 | 2.8 | 11.2 | 61.6 | ||
Lactate | (μmmol/l) | 1380–1900 | 2002 | 2547 | 3549 | ||
Qalb | ×10−3 | 1.7–9.0 | 8.0 | 18.6 | 45.5 | ||
Serum S-100 | (μg/l) | 0–0.05 | 0.01 | 0.10 | 0.16 |
↵1-150 p=0.019, one way analysis of variance (ANOVA) after logarithmic transformation.
MBP=Myelin basic protein; S-100=S-100 protein; Qalb=CSF/serum albumin ratio.